Загрузка...
Analysis of minimum target prices for production of entecavir to treat hepatitis B in high- and low-income countries
BACKGROUND: In 2013, an estimated 686,000 people died from hepatitis B virus (HBV) infection worldwide. Mass treatment programmes for hepatitis B will require very low drug costs. International treatment guidelines recommend first-line monotherapy with either entecavir or tenofovir disoproxil fumara...
Сохранить в:
| Опубликовано в: : | J Virus Erad |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Mediscript Ltd
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4946675/ https://ncbi.nlm.nih.gov/pubmed/27482399 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|